CL2022002363A1 - Una composición para su uso en el tratamiento de las anomalías de las células cervicales - Google Patents

Una composición para su uso en el tratamiento de las anomalías de las células cervicales

Info

Publication number
CL2022002363A1
CL2022002363A1 CL2022002363A CL2022002363A CL2022002363A1 CL 2022002363 A1 CL2022002363 A1 CL 2022002363A1 CL 2022002363 A CL2022002363 A CL 2022002363A CL 2022002363 A CL2022002363 A CL 2022002363A CL 2022002363 A1 CL2022002363 A1 CL 2022002363A1
Authority
CL
Chile
Prior art keywords
acid
composition
cervical cell
treatment
cell abnormalities
Prior art date
Application number
CL2022002363A
Other languages
English (en)
Spanish (es)
Inventor
Norbert Fuchs
Original Assignee
Selo Medical Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Selo Medical Gmbh filed Critical Selo Medical Gmbh
Publication of CL2022002363A1 publication Critical patent/CL2022002363A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CL2022002363A 2020-03-03 2022-08-30 Una composición para su uso en el tratamiento de las anomalías de las células cervicales CL2022002363A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP20160817.1A EP3875083A1 (en) 2020-03-03 2020-03-03 Composition for use in a treatment of cervical cell abnormalities comprising selenite compound and acid

Publications (1)

Publication Number Publication Date
CL2022002363A1 true CL2022002363A1 (es) 2023-03-31

Family

ID=69770560

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2022002363A CL2022002363A1 (es) 2020-03-03 2022-08-30 Una composición para su uso en el tratamiento de las anomalías de las células cervicales

Country Status (23)

Country Link
US (1) US20230092142A1 (cg-RX-API-DMAC7.html)
EP (2) EP3875083A1 (cg-RX-API-DMAC7.html)
JP (1) JP7840859B2 (cg-RX-API-DMAC7.html)
CN (1) CN115279358A (cg-RX-API-DMAC7.html)
AR (1) AR122387A1 (cg-RX-API-DMAC7.html)
AU (1) AU2021231205B2 (cg-RX-API-DMAC7.html)
BR (1) BR112022017436A2 (cg-RX-API-DMAC7.html)
CL (1) CL2022002363A1 (cg-RX-API-DMAC7.html)
CY (1) CY1126764T1 (cg-RX-API-DMAC7.html)
ES (1) ES2976058T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20240374T1 (cg-RX-API-DMAC7.html)
HU (1) HUE066384T2 (cg-RX-API-DMAC7.html)
IL (1) IL296146A (cg-RX-API-DMAC7.html)
MA (1) MA58262B1 (cg-RX-API-DMAC7.html)
MD (1) MD4084788T2 (cg-RX-API-DMAC7.html)
MX (1) MX2022010838A (cg-RX-API-DMAC7.html)
PL (1) PL4084788T3 (cg-RX-API-DMAC7.html)
RS (1) RS65349B1 (cg-RX-API-DMAC7.html)
SM (1) SMT202400126T1 (cg-RX-API-DMAC7.html)
TW (1) TW202146004A (cg-RX-API-DMAC7.html)
UA (1) UA130108C2 (cg-RX-API-DMAC7.html)
WO (1) WO2021175877A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202208848B (cg-RX-API-DMAC7.html)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2406377C (en) 2000-05-10 2010-07-06 Okopharm Forschungs-Und Entwicklungs-Gmbh Method for reducing the surface area of silicon dioxide
AT412758B (de) 2000-06-05 2005-07-25 Vis Vitalis Lizenz & Handels Verwendung einer selenithältigen lösung zur behandlung viraler erkrankungen
AT412703B (de) 2001-12-04 2005-06-27 Vis Vitalis Lizenz & Handels Verwendung von selenithältigen präparaten zur topischen oder bukkalen anwendung
AT511159A1 (de) * 2011-02-16 2012-09-15 Selo Medical Gmbh Pharmazeutische zusammensetzungen enthaltend selenit- oder selenathältige verbindungen
EP3616693A1 (en) * 2018-08-28 2020-03-04 Selo Medical GmbH Therapy of high-risk human papillomavirus infections

Also Published As

Publication number Publication date
JP2023516153A (ja) 2023-04-18
EP3875083A1 (en) 2021-09-08
MD4084788T2 (ro) 2024-06-30
BR112022017436A2 (pt) 2022-10-18
HUE066384T2 (hu) 2024-07-28
PL4084788T3 (pl) 2024-06-03
UA130108C2 (uk) 2025-11-12
EP4084788B1 (en) 2024-02-14
ZA202208848B (en) 2024-09-25
ES2976058T3 (es) 2024-07-22
AU2021231205A1 (en) 2022-09-01
MX2022010838A (es) 2022-09-27
CY1126764T1 (el) 2026-02-25
MA58262B1 (fr) 2024-03-29
WO2021175877A1 (en) 2021-09-10
CN115279358A (zh) 2022-11-01
RS65349B1 (sr) 2024-04-30
SMT202400126T1 (it) 2024-05-14
AR122387A1 (es) 2022-09-07
EP4084788A1 (en) 2022-11-09
HRP20240374T1 (hr) 2024-06-07
JP7840859B2 (ja) 2026-04-06
AU2021231205B2 (en) 2026-02-26
TW202146004A (zh) 2021-12-16
EP4084788C0 (en) 2024-02-14
CA3167015A1 (en) 2021-09-10
US20230092142A1 (en) 2023-03-23
IL296146A (en) 2022-11-01

Similar Documents

Publication Publication Date Title
PE20241305A1 (es) Analogos de amilina
Durie et al. Other mechanical methods for pre-induction cervical ripening
Di Renzo et al. The changing role of progesterone in preterm labour
PE20250018A1 (es) Formas de dosificacion farmaceuticas que comprenden (4s)-24-cloro-4-etil-73-fluoro-35- metoxi-32 ,5-dioxo-14-(trifluorometil)-32h-6-aza-3(4,1)-piridina-1(1)-[1,2,3]triazola- 2(1,2),7(1)-dibencenaheptafano-74-carboxamida
CL2021003034A1 (es) Métodos de tratamiento del síndrome de sjögren utilizando un inhibidor de la tirosina quinasa de bruton
AR001769A1 (es) Benzamida enterocinética composiciones farmacéuticas que las contienen procedimiento para la preparación de dichas composiciones farmacéuticas el uso de dichos compuestos para la manufactura de medicamentos y un procedimiento para su preparación
AR122387A1 (es) Composición para su uso en el tratamiento de anomalías de las células cervicales
AR085265A1 (es) Composiciones farmaceuticas que contienen compuestos con selenita
PE20242106A1 (es) Formas cristalinas de derivados de quinazolina, preparacion, composicion y uso de estas
CL2022003712A1 (es) Formulaciones
CL2025001309A1 (es) Formulaciones orales compactables de ibutamoren
RU2008147790A (ru) Фармацевтическая композиция на основе тилорона местного и наружного применения для лечения гнойно-деструктивных поражений слизистой и кожи, общесистемных заболеваний при иммунодефицитных состояниях
KR960705560A (ko) 산화질소 합성효소 기질 및(또는) 공여체, 또는 산화질소 저해제를 사용한 자궁 수축성 질환의 치료 방법(Treatment of Uterine Contractility Disorders with a Nitric Oxide Synthase Substrate and/or Donor, or a Nitric Oxide Inhibitor)
MX2025002228A (es) Metodos para el tratamiento o la profilaxis de la endometriosis
CL2021000197A1 (es) Terapia de infecciones de virus de papiloma humano de alto riesgo
Sheikher et al. Comparative evaluation of oral misoprostol, vaginal misoprostol and intracervical Folley’s catheter for induction of labour at term
GT200100002A (es) Pirazolo(4,3-e)diazepinas sustituidas novedosas, composiciones farmaceuticas que las contienen, su uso como productosmedicinales y procesos para prepararlas.
CL2022003743A1 (es) Formulaciones de tableta dispersable que comprenden dolutegravir
Lyndrup et al. Lamicel® does not promote induction of labour. A randomized controlled study
Singh et al. Role of uterine contraction in producing hemorrhages in rat fetuses after amniocentesis
Gusdon Jr et al. Complications caused by difficult removal of laminaria tents
Biswas et al. Induction of labour with foley catheter is better alternative to misoprostol
CN209916086U (zh) 一种用于甲状腺功能亢进症治疗的辅助装置
CN114053286B (zh) 一种药物组合物及其制备方法和应用
Manorama et al. Cervical Dilatation for Early Abortion (New Approach)